Research Topics
| P PitisuttithumSummaryAffiliation: Mahidol University Country: Thailand Publications
| Collaborators
|
Detail Information
Publications
HIV-1 prophylactic vaccine trials in ThailandPunnee Pitisuttithum
Clinical Infectious Diseases Research Unit, Faculty of Tropical Medicine, Mahidol University, 420 6 Ratchawithi Road, Bangkok 10400, Thailand
Curr HIV Res 3:17-30. 2005..With committed parties in medical science, government, industry and the community, we hope that we can achieve success in developing a safe and effective HIV vaccine in the near future...
Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan)Punnee Pitisuttithum
Faculty of Tropical Medicine, Mahidol University, Bangkok
Southeast Asian J Trop Med Public Health 42:1130-46. 2011....
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in ThailandPunnee Pitisuttithum
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
PLoS ONE 6:e27837. 2011..2% for prevention of HIV acquisition in HIV-uninfected adults participating in a community-based efficacy trial in Thailand...
A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin BP Pitisuttithum
Clinical Infectious Diseases Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Infect 43:226-33. 2001..To assess kinetic of cryptococci in the cerebrospinal fluid (CSF) and outcome of AIDS-associated cyptococcal meningitis after high-dose amphotericin B...
Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1Punnee Pitisuttithum
Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Acquir Immune Defic Syndr 37:1160-5. 2004..Using the B/E combination did not interfere with the response to either clade. Antibodies to AIDSVAX B/E were able to bind to oligomeric gp120 on the surface of cells infected with primary isolates of HIV-1...
Social harms in injecting drug users participating in the first phase III HIV vaccine trial in ThailandPunnee Pitisuttithum
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Med Assoc Thai 90:2442-8. 2007..To study related social harms due to identification with a group of participants in an HIV-1 vaccine trial who are potentially high risk for HIV/AIDS...
HIV vaccine research in Thailand: lessons learnedPunnee Pitisuttithum
Faculty of Tropical Medicine, Mahidol University, 40 6 Ratchavithi Road, Ratchathewi, Bangkok 10400, Thailand
Expert Rev Vaccines 7:311-7. 2008..However, many lessons learned can be utilized or modified for other vaccine trials, particularly vaccines against other infectious diseases prevalent in developing countries...
Activity of posaconazole in the treatment of central nervous system fungal infectionsPunnee Pitisuttithum
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420 6 Rajvithi Road, Bangkok 10400, Thailand
J Antimicrob Chemother 56:745-55. 2005..In this subanalysis, we report on those subjects in this trial who had a fungal infection that involved the CNS...
HIV-vaccine research and development in Thailand: evolution and challengesPunnee Pitisuttithum
Faculty of Tropical Medicine, Mahidol University 420 6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand
Vaccine 28:B45-9. 2010..However, there were different issues in recruitment process, follow up, social impact events and community involvement since the target participants were different...
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteersP Pitisuttithum
Vaccine Trial Centre VTC, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Vaccine 20:920-5. 2001..Cholera O139 in a human experimental challenge model to assess cholera vaccine efficacy (VE) in a cholera endemic area but with 4 days observation period before initiation of tetracycline to allow assessment of severity...
Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malariaS Looareesuwan
Department of Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand
Am J Trop Med Hyg 56:613-7. 1997..A seven-day regimen of artemether alone (750 mg) is also very effective, yet requires prolonged administration of drug after malaria symptoms disappear...
Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimensS Looareesuwan
Department of Clinical Tropical Medicine, Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand
Acta Trop 67:197-205. 1997..We conclude that 5- or 7-day regimens of sodium artesunate with a total dose of 1200-1600 mg are effective and safe in treating falciparum malaria acquired in Thailand...
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adultsSorachai Nitayaphan
Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
J Infect Dis 190:702-6. 2004..This vaccine combination was well tolerated and was immunogenic, meeting milestones for advancement to phase 3 evaluation...
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, ThailandPunnee Pitisuttithum
Department of Clinical Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
J Infect Dis 194:1661-71. 2006....
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adultsPunnee Pitisuttithum
Vaccine Trial Centre, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Siriraj Hospital, Mahidol University, 420 6 Rajvithi Road, Bangkok 10400, Thailand
J Infect Dis 188:219-27. 2003..There was no evidence of antigenic interference in HIV-specific humoral or cellular responses. The gp120 Thai E and SF2 vaccines were safe and immunogenic in combination and could be advanced into phase 3 testing...
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in ThailandChitraporn Karnasuta
Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Vaccine 23:2522-9. 2005..The results demonstrate that this HIV vaccine is a potent inducer of ADCC activity and may be an additional protection of this prime-boost vaccine in preventing HIV disease...
HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boostingR Paris
Department of Retrovirology, U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Tissue Antigens 64:251-6. 2004..These results strengthen the importance of assessing HLA class I distributions in conjunction with studies of vaccines designed to elicit cellular immunity in different populations...
Microsporidium: modified technique for light microscopic diagnosisB Punpoowong
Department of Tropical Pathology, Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Med Assoc Thai 78:251-4. 1995..Less time and less reagent are required by this modified technique than the conventional method...
Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisininS Looareesuwan
Department of Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand
Ann Trop Med Parasitol 90:21-28. 1996..Comparisons with other conventional antimalarial drugs in a large, double-blind, randomized trial and studies of dihydroartemisinin in combination with other, long-acting antimalarials are needed...
Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trialsWirach Maek-A-Nantawat
Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok 10700, Thailand
J Med Assoc Thai 86:299-307. 2003..0001). All of the volunteers expressed the beneficial expectations as knowledge gain, social contribution, feelings of having gained merit and self-benefits from health check-ups...
Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003Pravan Suntharasamai
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Addiction 104:235-42. 2009..To determine if incarceration was associated with human immunodeficiency virus (HIV) infection and identify risk factors for incarceration among injection drug users (IDUs) participating in an HIV vaccine trial in Bangkok...
Effects of cigarette smoking on quinine pharmacokinetics in malariaS Pukrittayakamee
Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand
Eur J Clin Pharmacol 58:315-9. 2002..2 micro g/ml/day and 4.8 micro g/ml/day, respectively. CONCLUSION: These results indicated that cigarette smoking has no significant effects on quinine pharmacokinetics or the therapeutic response in patients with falciparum malaria...
Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infectionAneley Getahun
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Med Assoc Thai 89:1472-8. 2006..9%, 14.7% and 6.9%, respectively. CONCLUSION: GPO-vir was well tolerated and effective in increasing CD4 cell count and suppressing plasma viremia in advanced HIV infection during the 48 weeks follow-up period...
Safety and efficacy of CKBM-A01, a Chinese herbal medicine, among asymptomatic HIV patientsWirach Maek-A-Nantawat
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 40:494-501. 2009..019). CKBM-A01 appeared to be safe but gave no significant improvement in QoL in asymptomatic HIV patients, and gave no significant improvement in the treatment of HIV based on CD4 cell counts and viral loads...
Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patientsValai Bussaratid
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Med Assoc Thai 85:757-64. 2002..albicans, C. glabrata, and C. krusei ranged from 0.125-32 (median=0.250), 4-64 (median=2), and 8 g/L respectively. This study showed that the MICs to fluconazole of oropharyngeal Candida was a good predictor of the therapeutic responses...
6-month evaluation of JinHuang Chinese herbal medicine study in asymptomatic HIV infected ThaisWirach Maek-A-Nantawat
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 34:379-84. 2003..Most of the patients felt that the quality of life was better in terms of better appetite, good sleep and healthy during study participation, however, these were subjective...
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patientsEi Ei Tin
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 36:362-9. 2005..043). GPO-VIR is an inexpensive and effective antiretroviral drug regimen for initiating treatment of naïve patients, but careful assessment for lipodystrophy is necessary, especially after one year of treatment...
Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in ThailandMaie Aramaki
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok Thailand
Southeast Asian J Trop Med Public Health 41:138-45. 2010..001). The incidence of IRIS in advanced adult HIV-infected patients in Thailand was lower than that reported from Europe and the United States, which may be attributable to deferment of HAART after diagnosing opportunistic infections...
Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomesNimfa M Putong
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 33:346-51. 2002..Among those who survived, only 11.4% had been successfully treated; the rest had not improved due to relapse (2.9%), therapeutic failure (8.8%), treatment in progress (5.9%), and failure to complete treatment (10.7%)...
Psychosocial burden of women with abnormal Pap smearsBenjaluck Phonrat
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 40:593-601. 2009....
Clinical features, aetiology and short-term outcome of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, ThailandAriane Knauer
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Wien Klin Wochenschr 117:49-55. 2005..6% had clinically improved. The cumulative survival after 28 days was highest among PCP patients, followed by bacterial pneumonia, TB and fungal pneumonia, but these differences were statistically not significant (p = 0.453)...
Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in ThailandDarawan Thapinta
Faculty of Nursing and Research Institute of Health Sciences, Chiang Mai University, Chiang Mai, Thailand
J Acquir Immune Defic Syndr 30:503-13. 2002..The frequent presence of mixed (altruistic and nonaltruistic) motives at initial contact suggests that motivation for trials is more complex than has been previously acknowledged...
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1Jerome H Kim
U S Military HIV Research Program, Rockville, Maryland 20850, USA
AIDS Res Hum Retroviruses 19:807-16. 2003..Whether the NAb detected by the CM235M4-C4.6/A3R5 system is qualitatively different from those in more traditional NP03/H9 assays will require further study...
Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, ThailandFrits van Griensvan
Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi
AIDS 18:295-301. 2004..CONCLUSIONS: Injection drug use and needle sharing decreased during the first 12 months of the trial. No increases in risk behavior in relation to beliefs about vaccine protection against HIV infection could be identified...
Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, ThailandSuphak Vanichseni
Thailand Ministry of Public Health US Centers for Disease Control and Prevention Collaboration, Nonthaburi
AIDS 18:311-6. 2004....
Behavioral and social issues among volunteers in a preventive HIV vaccine trial in ThailandRichard A Jenkins
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Acquir Immune Defic Syndr 40:592-9. 2005..Findings add to the evidence that preventive HIV vaccine trials are feasible in Thailand...
Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 countSomsit Tansuphaswadikul
Bamrasnaradura Institute, Ministry of Public Health, Nonthaburi, Thailand
Asian Pac J Allergy Immunol 25:147-54. 2007....
Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continentsPaul M Coplan
Merck Research Laboratories, West Point, Pennsylvania, USA
J Infect Dis 191:1427-34. 2005..Therefore, we quantified the cross-clade reactivity, among unvaccinated individuals, of anti-HIV-1 T cell responses to the infecting HIV-1 clade relative to other major circulating clades...
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad
The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Clin Infect Dis 42:1726-34. 2006..Antifungal therapy is often required for long periods. Safety data from the clinical development program of the triazole antifungal agent, posaconazole, were analyzed...
Clinical features, etiology and short term outcomes of interstitial pneumonitis in HIV/AIDS patientsSomsit Tansuphasawadikul
Bamrasnaradura Hospital, Ministry of Public Health, Nonthaburi, Thailand
Southeast Asian J Trop Med Public Health 36:1469-78. 2005..The cumulative survival after 28 days was highest among PCP patients, followed by bacterial pneumonia, tuberculosis and fungal pneumonia, but this difference was not statistically significant (p = 0.0453)...
Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patientsSomsit Tansuphaswadikul
Bamrasnaradura Infectious Disease Institute, Department of Disease Control, Nonthaburi
J Med Assoc Thai 89:1677-85. 2006..It can be an alternative regimen to lower hospital based care and improve cost effective for source limiting health care centers...
